Lynnsie Ruffino
- Cancer Research top 2%
- MicroRNA in disease regulation 3
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 2
-
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 2
-
- Cancer Mechanisms and Therapy 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- interferon and immune responses 1
-
- Skin and Cellular Biology Research 1
- Co-authors
- David BrownMichael OmotolaKevin KelnarAndreas G. BaderJason F. WigginsLubna PatrawalaJohn DiGiovanniKaoru Kiguchi
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
Lynnsie Ruffino
10 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 815
- Molecular Biology 1.0k
- Oncology 213
- Pathology and Forensic Medicine 100
- Surgery 195
Countries citing papers authored by Lynnsie Ruffino
This map shows the geographic impact of Lynnsie Ruffino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynnsie Ruffino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynnsie Ruffino more than expected).
Fields of papers citing papers by Lynnsie Ruffino
This network shows the impact of papers produced by Lynnsie Ruffino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynnsie Ruffino. The network helps show where Lynnsie Ruffino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lynnsie Ruffino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 32 | |
| 2 | Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34breakdown → | 2010 | 532 |
| 3 | 2010 | 10 | |
| 4 | 2009 | 398 | |
| 5 | 2007 | 17 | |
| 6 | 2007 | 49 | |
| 7 | 2005 | 33 | |
| 8 | 2004 | 19 | |
| 9 | Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. | 2003 | 60 |
| 10 | Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. | 2001 | 142 |
About Lynnsie Ruffino
Lynnsie Ruffino is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), interferon and immune responses (1 paper) and Skin and Cellular Biology Research (1 paper). The work is most often cited by research in Cancer Research (815 citations), Molecular Biology (1.0k citations) and Oncology (213 citations). Lynnsie Ruffino has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include David Brown, Michael Omotola, Kevin Kelnar, Andreas G. Bader, Jason F. Wiggins, Lubna Patrawala, John DiGiovanni, Kaoru Kiguchi, Joanne B. Weidhaas and Phong Trang. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.